This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Entegris Acquires ATMI For $1B

NEW YORK (The Deal) -- Entegris  (ENTG) announced Tuesday it would pay $1.15 billion for ATMI (ATMI) sending shares of the two semiconductor suppliers sharply higher.

Entegris rose $1.13, or 11%, to $11.41, while ATMI gained $6.86, or 25.5%, to $33.79.

ATMI investors will receive $34 per share, a premium of more than 26% above Monday's close. The valuation equates to $850 million when backing out ATMI's cash, which includes $170 million in expected proceeds from the pending sale of the target's life sciences business to Pall (PLL).

Entegris CEO Bertrand Loy said the purchase will help the buyer manage the growing cost and complexity of new semiconductor manufacturing processes.

ATMI provides specialty materials for semiconductor and microelectronics manufacturers. The Danbury, Conn., company generated $86 million in 2013 Ebitda, against sales of $361 million. Entegris said it projects that it will have more than $1 billion in sales following the purchase.

Stifel, Nicolaus analyst Patrick Ho observed in a Tuesday report that the deal's valuation of 2.7 times sales falls within the range of 2-to-3 times sales that is typical for the semiconductor capital sector.

ATMI disclosed that it had retained Barclays Capital to explore strategic options in November.

Pall agreed to pay $185 million for ATMI's life sciences unit in December. The sale to Entegris is conditioned upon closing the deal with Pall.

Billerica, Mass.-based Entegris said it expects to complete the purchase of ATMI in the second quarter of 2014.

Barry O'Brien and Thomas Stokes of Goldman Sachs  (GS) and a team from Ropes & Gray led by Craig Marcus, Tom Draper, Eric Elfman, Renata Ferrari and Peter Alpert advised Entegris.

Goldman is also arranging financing for Entegris.

ATMI retained Barclays bankers Ken Grahame, Paul Collins and Laurence Braham, and Weil Gotshal & Manges lawyers including Thomas Roberts, Matthew Gilroy, Mark Hoenig, Paul Wessel, John Brockland, Annemargaret Connolly and Richard Ginsburg.

Barclays and Weil also advised ATMI on the life sciences divestiture.

-- Lou Whiteman contributed to this report.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7870 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs